Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
International Journal of Molecular Sciences|December 23, 2023
Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?Silvia Spoto, Stefania Basili, Roberto Cangemi, et al.
Journal of Infection in Developing Countries|June 12, 2020
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease controlSilvia Angeletti, Giancarlo Ceccarelli, Riccardo Bazzardi, et al.
Preparative Biochemistry & Biotechnology|October 10, 2024
Ethanol and 2-phenylethanol production by bee-isolated Meyerozyma caribbica strainsEduardo Dias Fenner, Stéfany Kell Bressan, Angela Alves Dos Santos, et al.
Current Microbiology|December 11, 2025
Prospecting Bioactive Potential and Phenolic Compounds in Brazilian Yeast StrainsViviani Tadioto, Angela Alves Dos Santos, Anderson Giehl, et al.
Nature Communications|July 19, 2020
Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogrammingKenneth C P Cheung, Silvia Fanti, Claudio Mauro, et al.
The Journal of Biological Chemistry|September 10, 2013
Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallinP Patrizia Mangione, Gennaro Esposito, Annalisa Relini, et al.
Frontiers in Immunology|May 8, 2023
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profilesLuca Navarini, Marta Vomero, Damiano Currado, et al.
Scientific Reports|April 22, 2017
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivoSara Raimondi, Riccardo Porcari, P Patrizia Mangione, et al.
Arthritis and Rheumatism|September 25, 2012
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockersMartina Fabris, Luca Quartuccio, Ed Vital, et al.
Pageof 19